chr15-78590479-T-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000745.4(CHRNA5):c.1088T>A(p.Leu363Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,614,196 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.016   (  54   hom.,  cov: 32) 
 Exomes 𝑓:  0.0017   (  62   hom.  ) 
Consequence
 CHRNA5
NM_000745.4 missense
NM_000745.4 missense
Scores
 6
 8
 4
Clinical Significance
Conservation
 PhyloP100:  7.99  
Publications
12 publications found 
Genes affected
 CHRNA5  (HGNC:1959):  (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014962435). 
BP6
Variant 15-78590479-T-A is Benign according to our data. Variant chr15-78590479-T-A is described in ClinVar as Benign. ClinVar VariationId is 714661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0525  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0157  AC: 2387AN: 152192Hom.:  54  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2387
AN: 
152192
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00416  AC: 1046AN: 251252 AF XY:  0.00297   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1046
AN: 
251252
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00171  AC: 2503AN: 1461886Hom.:  62  Cov.: 31 AF XY:  0.00151  AC XY: 1096AN XY: 727242 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2503
AN: 
1461886
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
1096
AN XY: 
727242
show subpopulations 
African (AFR) 
 AF: 
AC: 
1887
AN: 
33480
American (AMR) 
 AF: 
AC: 
119
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
144
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
13
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
17
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
101
AN: 
1112010
Other (OTH) 
 AF: 
AC: 
222
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.494 
Heterozygous variant carriers
 0 
 160 
 319 
 479 
 638 
 798 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 68 
 136 
 204 
 272 
 340 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0157  AC: 2398AN: 152310Hom.:  54  Cov.: 32 AF XY:  0.0151  AC XY: 1122AN XY: 74486 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2398
AN: 
152310
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1122
AN XY: 
74486
show subpopulations 
African (AFR) 
 AF: 
AC: 
2261
AN: 
41556
American (AMR) 
 AF: 
AC: 
75
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
18
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10628
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20
AN: 
68032
Other (OTH) 
 AF: 
AC: 
22
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.509 
Heterozygous variant carriers
 0 
 120 
 240 
 361 
 481 
 601 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 26 
 52 
 78 
 104 
 130 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ESP6500AA 
 AF: 
AC: 
228
ESP6500EA 
 AF: 
AC: 
5
ExAC 
 AF: 
AC: 
631
Asia WGS 
 AF: 
AC: 
17
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Uncertain 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Uncertain 
 DANN 
 Uncertain 
 DEOGEN2 
 Pathogenic 
D 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
D 
 MetaRNN 
 Benign 
T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Pathogenic 
M 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Uncertain 
D 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D 
 Sift4G 
 Uncertain 
D 
 Polyphen 
D 
 Vest4 
 MVP 
 MPC 
 ClinPred 
T 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.